Puma Biotechnology shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q3 sales guidance above estimates. Also, the company raised its FY25 sales guidance above estimates.

2025-11-08 00:15

在该公司报告第三季度财务业绩好于预期并发布第三季度销售指引高于预期后，Puma Biotechnology股价走高。此外，该公司还将25财年的销售指引提高至高于预期。